2020
DOI: 10.1177/2324709620963714
|View full text |Cite
|
Sign up to set email alerts
|

An Aggressive Presentation of Merkel Cell Carcinoma: A Case Report

Abstract: Merkel cell carcinoma (MCC) is a rare malignant neuroendocrine tumor more common in immunosuppressed old patients. It is characterized by a high frequency of local recurrence, regional nodal metastasis, distant metastasis, and low survival rate. The diagnosis of MCC is challenging due to its rarity and can be clinically mistaken for other skin cancer. We report a case of locally advanced MCC of the left groin with aggressive behavior that was finally controlled with a combined treatment and we collected data f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Merkel cell carcinoma (MCC) is a rare and aggressive primary cutaneous neuroendocrine carcinoma [1]. It is characterized by a high frequency of local recurrence, regional nodal metastasis, distant metastasis, and a low survival rate [2]. Its incidence has increased over the last thirty years.…”
Section: Introductionmentioning
confidence: 99%
“…Merkel cell carcinoma (MCC) is a rare and aggressive primary cutaneous neuroendocrine carcinoma [1]. It is characterized by a high frequency of local recurrence, regional nodal metastasis, distant metastasis, and a low survival rate [2]. Its incidence has increased over the last thirty years.…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, it needs combined therapeutic management. 1,6 This study aimed to present a rare case of MCC, on an unusual site, associated with chronic lymphocytic leukemia (CLL) and its prognosis.…”
Section: Introductionmentioning
confidence: 99%
“…In this regard, diagnostic management of these patients requires the entire body examination of the lymph nodes and all required laboratory tests or imaging to rule out differential diagnoses such as basal cell carcinoma (BCC), squamous cell carcinoma, adnexal tumor, amelanotic melanoma, epidermoid cysts, pyogenic granuloma, angiosarcoma, and lymphoma. Consequently, it needs combined therapeutic management 1,6 . This study aimed to present a rare case of MCC, on an unusual site, associated with chronic lymphocytic leukemia (CLL) and its prognosis.…”
Section: Introductionmentioning
confidence: 99%